@entity1904 used as a marker of XXXX in the intensive care unit.

@entity1 @entity326 @entity1904 @entity3124 @entity281 @entity2259 @entity1851
OBJECTIVE: To determine the value of @entity1904 (ProCT) as a marker of @entity281 in @entity3124 @entity1 . DESIGN: Prospective, observational study. SETTING: Medicosurgical department of intensive care (31 beds). @entity1 : One hundred eleven infected and 79 noninfected @entity1 . INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: ProCT and @entity1851 ( @entity1851 ) concentrations were monitored daily. The best cutoff values for ProCT and @entity1851 were 0.6 ng/mL and 7.9 mg/dL, respectively. Compared with @entity1851 , ProCT had a lower sensitivity (67.6 vs. 71.8), specificity (61.3 vs. 66.6), and area under the receiver operating characteristic curve (0.66 vs. 0.78, p < .05). The combination of ProCT and @entity1851 increased the specificity for @entity281 to 82.3%. In the infected @entity1 , plasma ProCT, but not @entity1851 , values were higher in nonsurvivors than in survivors. Infected @entity1 with @entity2259 had higher ProCT concentrations than those without @entity2259 , but similar @entity1851 concentrations. ProCT levels were particularly high in @entity326 @entity1 . CONCLUSIONS: ProCT is not a better marker of @entity281 than @entity1851 in @entity3124 @entity1 , but it can represent a useful adjunctive parameter to identify @entity281 and is a useful marker of the severity of @entity281 .
